![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22409-22413, August 6, 1999
From the Musculoskeletal Research Laboratory, Departments of
Orthopaedics and Rehabilitation, In this study, we test the hypothesis that the
carboxyl noncollagenous (NC1) domain of collagen X is sufficient to
direct multimer formation without a triple helix. Two peptides
containing the NC1 domain of avian collagen X have been synthesized
using a bacterial expression system and their properties characterized. One peptide consists only of the NC1 domain, and the other is a
chimeric molecule with a noncollagenous A domain of matrilin-1 fused to
the N terminus of NC1. The NC1 peptide alone forms a 45-kDa trimer
under native conditions, suggesting that NC1 contains all the
information for trimerization without any triple helical residues. This
trimeric association is highly thermostable without intermolecular
disulfide bonds. This indicates that the NC1 domain contributes to the
remarkable structural stability of collagen X. Chemical cross-linking
of the NC1 trimer results in a series of varying sized multimers, the
smallest of which is a trimer. Therefore the NC1 trimer is sufficient
to form higher order multimers. The chimeric A-NC1 peptide forms a
homotrimer by itself, and a series of heterotrimers with the NC1
peptide via the NC1 domain. Thus the NC1(X) domain directs multimer
formation, even in a noncollagenous molecule.
Type X collagen is expressed specifically by hypertrophic
chondrocytes at the transition of cartilage to bone during endochondral bone formation (1, 2). Type X collagen is essential for the structural
organization of the matrix preceding calcification (3, 4), occurring in
two forms: one is a pericellular mat (5), which probably represents a
multimeric form of type X collagen itself (6); the other is in
association with type II collagen containing fibrils where it also
interacts with proteoglycans (7, 8). This interaction may be critical
for the compartmentalization of matrix components during development
(9).
The importance of type X collagen during bone development is evidenced
by its mutations in a human limb disorder Schmid metaphyseal chondrodysplasia (SMCD)1 (10,
11). The type X collagen molecule consists of three The NC1 domain of type X collagen is highly conserved among species
(15), with that of the human and avian molecules sharing 77.7%
identity at the amino acid level. Potentially important structural
features, such as 13 tyrosine residues, an unpaired cysteine residue,
and a putative N-linked oligosaccharide attachment site are
all conserved within the NC1 domain of human and avian type X collagen.
Also, all the residues within the NC1 domain mutated in the SMCD
patients are conserved between human and avian It has been proposed that the NC1 of type X is important for the triple
helical assembly of the collagen, similar to the function of the NC1
domains from fibrillar collagens (10). Recent cloning data have shown that there is a family of molecules,
which include both collagenous and noncollagenous molecules, that
contain a homologous NC1 domain at their C termini (Fig. 1). The collagenous molecules include
In this study, we have analyzed the functions of the NC1 domain by
expressing and characterizing two noncollagenous peptides containing
the NC1 domain from avian Construction and Expression of Recombinant NC1 and
A-NC1--
For the NC1 construct, a cDNA fragment correspondent to
the 162 amino acid sequence of the NC1 domain from avian Purification and Characterization of Recombinant Peptides under
Native Conditions--
Cell pellets were suspended in lysis buffer (50 mM NaH2PO4, 1 M NaCl,
0.1% Tween 20, 1 mM lysozyme, 1 mM PMSF, 10 mM imidazole, pH 8.0) and incubated in ice for 30 min.
After centrifugation at 10,000 × g for 30 min, the
supernatant was loaded on Ni-NTA slurry column (Qiagen). After washing
with washing buffer (50 mM NaH2PO4,
1 M NaCl, 0.1% Tween 20, 1 mM PMSF, 40 mM imidazole, pH 8.0), the recombinant peptide was eluted
with elution buffer (50 mM NaH2PO4,
1 M NaCl, 0.1% Tween 20, 1 mM PMSF, 300 mM imidazole, pH 8.0).
Peptide Purification under Denatured Conditions and
Refolding--
Cell pellets were incubated in urea lysis buffer (8 M urea, 0.1 M NaH2PO4,
0.01 M Tris-HCl, pH 8.0) at room temperature overnight with
shaking. After centrifugation at 10,000 × g for 30 min, the supernatant was loaded on Ni-NTA slurry column. For
purification under denatured conditions, the column was eluted with 8 M urea, 0.1 M NaH2PO4,
and 0.01 M Tris-HCl, pH 4.5. For refolding, the column was
washed with wash buffer (8 M urea, 0.1 M
NaH2PO4, 0.01 M Tris-HCl, pH 6.3)
until A280 to 0.01, then the slurry was divided into two parts for refolding in liquid and solid phases. For the liquid
phase folding, a denatured peptide was eluted with elution buffer (8 M urea, 0.1 M NaH2PO4,
0.01 M Tris-HCl, pH 4.5), followed by dialysis in urea step
gradient buffers (6-0 M urea, 500 mM NaCl,
20% glycerol, 20 mM Tris-HCl, 1 mM PMSF, pH
7.4) in an 8 h refolding process. For the solid phase folding, the
peptide was first refolded on the column with the same urea step
gradient buffers over the same period of time (8 h). After refolding,
the peptide was eluted with imidazole elution buffer (400 mM imidazole, 500 mM NaCl, 20% glycerol, 20 mM Tris-HCl, 1 mM PMSF, pH 7.4). For
co-refolding of the NC1 and A2-NC1 peptides, equal amounts of the
bacterial cultures expressing the NC1 and A2-NC1 peptides were mixed.
The peptide mixture was purified and refolded on a solid phase,
identical to the procedure for a single peptide described above. The
concentration of total protein was determined with BCA protein assay
reagent kit (Pierce).
SDS-Polyacrylamide Gel Electrophoresis and Cross-linking
Assay--
Cross-linking was carried out with BS3
(Bis(sulfosuccinimidyl)suberate) (Pierce), a water-insoluble,
homobifunction-N-hydroxysuccinimide ester analog (spacer arm
length 11.4 Å). 10 µM of the refolded NC1 peptides were
mixed with various concentration of BS3 and incubated at
room temperature with a gentle shake for 1 h followed by adding
Tris-HCl buffer (final concentration: 50 mM) to stop the reaction.
The samples were loaded on a 10% SDS-PAGE for electrophoresis. For
reducing conditions, samples were mixed with 5× SDS gel loading buffer
containing 15% Matrix-assisted Laser Desorption Ionization Mass
Spectrometry--
Refolded NC1 peptides (300 µg/ml in 500 mM NaCl, 20% glycerol, 500 mM
NaH2PO4, pH 7.4) were prepared for mass
spectrometry by the dried droplet method in which the protein solution
and a solution of sinapinic acid matrix (0.5 µl each) were mixed and air-dried. The crystals were then rinsed with 10 µl of 0.1%
trifluoroacetic acid. Spectrum was obtained with STR Perseptive
Biosystems (Framingham, MA). It primarily shows the monomeric NC1
(20,554 Da), with small peaks corresponding to dimer (41,102 Da) and
trimer (61,687 Da). Another spectrum was obtained in similar fasion but
after heating the sample to 90 °C for 5 min with similar results.
Construction of Two Peptides Containing the NC1 Domain and
Experimental Design--
To characterize the function of the NC1(X)
domain, two molecules containing this domain were created. The first
peptide, NC1, consists of the C-terminal 162 amino acid residues of
To test whether the NC1 domain is sufficient to direct trimer formation
of a noncollagenous molecule, the second peptide, A-NC1, is comprised
of two domains: the NC1 domain at the C terminus and the entire A2
domain (194 amino acid residues) of avian CMP at the N terminus (Fig.
2B). Previous studies (29) have used a mini-CMP, which
comprises a heptad-repeat domain at the C terminus and the A2 domain at
the N terminus (Fig. 2B), to demonstrate that the
heptad-repeat domain forms a three-chain coiled-coil thereby
facilitating the trimer formation of the molecule. This trimer then is
covalently stabilized by the intermolecular disulfide bonds involving
the two cysteines at the N terminus of the heptad repeat (29). The
chimeric peptide construct that we designed deleted the coiled-coil
domain and the cysteine residues, and replaced these with the X-NC1
domain. If the NC1 domain functions as the coiled-coil domain, it would
direct trimer formation of the A-NC1, as does the coiled-coil in
mini-CMP. Finally, the two peptides, A-NC1 and NC1, would be refolded
together in vitro. This is to test whether they form
heterotrimers via the NC1 domain. The number of the co-refolding
products would confirm their trimeric states (i.e. four
products are expected for the formation of trimers) (Fig.
2C).
Bacterial Synthesis and Assembly of a Native NC1 Peptide into a
Trimeric Form--
We observed that E. coli containing a
His-tag bacterial expression vector encoding the NC1 domain assembled
the newly synthesized peptides into a trimeric form under native
conditions. Upon induction by
isopropylthio- In Vitro Folding--
Analysis of the intracellular location of
the recombinant protein within the bacteria indicated that less than
10% of the protein was in a soluble form; more than 90% of the
recombinant protein was insoluble in inclusion bodies (data not shown).
To isolate large quantities of the recombinant protein for further analysis, the insoluble fraction was purified under denaturing conditions. The denatured peptide existed as a 20-kDa monomer, and a
40-kDa putative dimer. However, no 45-kDa trimeric form was visible
(Fig. 3B, lane 4).
The denatured peptide was tested for its ability to undergo refolding
in solution by a step wise dilution of denaturants (see "Materials
and Methods"). The resulting material formed an insoluble precipitate
that upon SDS-PAGE analysis was still monomers and dimers (Fig.
4, lanes 2 and 3).
We reasoned that to achieve the native trimeric state may require that
the NC1 peptide monomers first undergo intramolecular folding to
achieve a stable monomeric configuration, before they undergo
intermolecular association to form a trimer. To test this hypothesis,
we prevented premature intermolecular aggregation by immobilizing one
end of the peptide through its His-tag to a Ni-NTA column. The
immobilized peptide was then renatured with the same step wise dilution
of denaturants as employed in solution. After the solid-phase
refolding, the renatured material that was eluted from the column was a
45-kDa trimer (Fig. 4, lane 4). It was shifted to a 20-kDa
monomer after heating at 100 °C (Fig. 4, lane 5).
To demonstrate that the refolded NC1, seen as a 45-kDa band on gels,
was actually a trimer, matrix-assisted laser desorption ionization mass
spectrometry was performed. The refolded peptides were subject to
dissociation process by removing salts from the solution. The resulting
spectrum primarily showed the monomeric peak at 20.6 kDa, with small
dimer and trimer peaks at 41.1 and 61.7 kDa, respectively. Thus, the
refolded NC1 was a trimer with a molecular mass of 61.7 kDa.
Thermal Stability of the NC1 Trimer--
To determine the thermal
stability of the NC1 domain, the refolded NC1 peptides were incubated
at different temperatures (70, 80, 90, and 100 °C) before analysis
by SDS-PAGE. The trimers were resistant to thermal denaturation up to
90 °C under reducing conditions (Fig.
5). At 90 °C, the majority of the NC1
domain still remained as trimers (Fig. 5). Only at 100 °C were the
trimers separated completely into monomers (Fig. 5).
To determine whether disulfide bonds were involved in the thermal
stability of the NC1 domain, the NC1 trimers were incubated in the
absence of reducing reagents. Similar to the results under reducing
conditions, the trimers became completely separated only at 100 °C
(Fig. 5). Thus, disulfide bonds were not involved in the thermal
stability of the NC1 trimer.
Multimeric Forms of NC1 by Cross-linking--
To further
characterize the association of the NC1 peptides, we performed a
cross-linking experiment with a cross-linker BS3. The
spacer arm length of BS3 is 11.4 Å. Therefore, neighboring
peptides whose distance is equal to or less than 11.4 Å will be
covalently cross-linked by BS3. The refolded NC1 peptides
were incubated in a series of solutions with different concentrations
of BS3 (Fig. 6). In a
solution with an equal ratio of cross-linker to NC1, a ladder of bands
appeared above the trimer (Fig. 6, arrows in the
middle panel). The smallest of this series of
bands was the 45-kDa NC1 trimer. Therefore, the NC1 trimer formed
higher order multimers in solution. After heating to 100 °C, the
cross-linked sample included, in the least, monomers (20 kDa), dimers
(40 kDa), and trimers (60 kDa) (Fig. 6, arrows in the
right panel). The unheated native NC1 trimer migrated at the
45-kDa position faster than a heated denatured trimer. This is probably
because of the compact configuration of the native peptides. With
excessive cross-linker (1,000 times of that of NC1), the NC1 peptides
remained as a high molecular polymer under both heating and nonheating
conditions (Fig. 6, arrowheads).
Trimer Formation of the Chimeric A-NC1 Peptide--
To test
whether the NC1 domain facilitates trimer formation of a noncollagenous
molecule, a chimeric A-NC1 peptide was purified under denatured
conditions and refolded on a solid phase. With SDS-PAGE performed
without heating, this material contained three forms (Fig.
7). The smallest was the 40-kDa form, the
predicted molecular mass of an A-NC1 monomer. The second was 100 kDa,
consistent with a native trimeric form following refolding (see below).
The third was 200 kDa, twice the molecular mass of the trimer and most
probably a hexamer. After heating to 100 °C, both of the multimeric
forms shifted to the monomeric 40-kDa form (Fig. 7).
To demonstrate that the 100-kDa form was, in fact, an A-NC1 trimer,
denatured A-NC1 peptide was refolded together with the NC1 peptide. If
both the A-NC1 and the NC1 peptides form trimers, co-refolding of these
two peptides should result in four products, the 100 kDa
(A-NC1)3, the 45 kDa (NC1)3, and two
heterotrimers (A-NC1)2NC1 and A-NC1(NC1)2
between 100 and 45 kDa (Fig. 2). The molecular mass of the
(A-NC1)2NC1 should be above 72.5 kDa (the average of the
molecular weights of the two homotrimers), and the molecular mass of
the A-NC1(NC1)2 is expected to be below 72.5 kDa.
Upon analysis by SDS-PAGE, the co-refolded material shows the predicted
four products (Fig. 8). Thus, the A-NC1
peptide and the NC1 peptide can form heterotrimers via the NC1
domain.
In collagens, it is well established that triple helix formation
is initiated at the carboxyl-terminal end, where the individual chains
are maintained in register by interchain disulfide links (31). In some
collagens (e.g. homotrimer type XII collagen), disulfide
bond formation requires triple helix and thus will not occur in the
absence of prolylhydroxylase (32). Formation of the type IX collagen
NC1 heterotrimers also requires some adjacent triple helical segments,
although in this case, a triple helical conformation is not necessary
(33). The trimeric NC1 domain of avian type X collagen is unique in
that it does not contain interchain disulfide bonds. Another puzzling
fact is that a homologous NC1(X) domain has been found at the C
terminus of some molecules that do not contain any triple helical
sequences at all (Fig. 1).
We have demonstrated here that peptides of the NC1 domain of type X are
sufficient to form trimers without adjacent triple helical segments.
This suggests that the NC1 domain alone is sufficient for chain
association and proper trimeric assembly. The NC1(X) forms an
extraordinary stable trimer without any disulfide bonds. The trimeric
interaction of the NC1 is resistant to denaturing conditions of
SDS-PAGE, as is that of the native molecule (30). Under such conditions
noncovalently linked subunits of most molecules would be dissociated.
For example, the CMP trimer, which is held together by a C-terminal
coiled-coil, is dissociated into monomers under denaturing conditions
if disulfide bonds are not present (29). In contrast, we have shown
that, when the coiled-coil domain of CMP is replaced by the NC1 domain,
the NC1 domain is able to hold the mini-CMP trimer together under such
reducing conditions.
The noncovalent association of the NC1(X) is highly thermostable. Only
at 100 °C did the trimer become completely dissociated. It was known
that the intact native type X collagen can be dissociated only by
boiling in the presence of detergents (30). Our data suggest that the
NC1 domain is responsible for this remarkable stability of collagen X. The stability of the NC1 may also contribute to the rapid renaturation
of collagen X after thermal denaturation. The denaturation temperature
(Tm) of the helical structure of avian collagen X is
47 °C (30). It has been found previously that, after thermal
denaturation at 55 °C, more than 60% of the helical structure from
intact type X was reformed after 40 min. However, without the NC1, the
collagenous domain renatured 15% at most, even after 24 h (30).
Our data have shown that the NC1 peptide remains as a trimer under
thermal denaturation up to 90 °C. This suggests that at a denaturing
temperature between 47 °C and 90 °C the NC1 domain would still
hold trimers together, thus maintaining proper chain registration and
allowing rapid renaturation of the adjacent triple helix.
In vitro refolding of NC1 suggests that to achieve proper
trimeric assembly of the molecule, premature interchain association has
to be prevented. It is possible that a chaperon may perform such a
function in vivo, as does immobilization on a solid phase in vitro. This "chaperon" hypothesis is consistent with
the recent finding that protein disulfide isomerase, a chaperon
candidate molecule, binds to type X during folding to prevent premature association by an interaction that is not dependent on the presence of
cysteines in the peptide (34).
Our data suggest that the NC1 domain of collagen X directs two levels
of polymerization. The first is from monomer to trimer, and the second
is from trimer to multimers. This multimeric association exists in
solution, as revealed by the cross-linking experiment. The distance of
neighboring trimers should be no more than 11.4 Å (1.14 nm), which is
the spacer arm length of the cross-linker BS3. Because the
NC1 domain is sufficient to form intermolecular self-associations
without the collagenous domain, the NC1 domain may act as a nucleation
site to initiate the multimeric self-assembly of collagen X. This
provides a structural mechanism for the electron microscopic
observations that type X undergoes self-association (35) and forms a
multimeric hexagonal lattice (6).
We have shown that the NC1(X) domain is also capable of directing
trimer and higher order multimer formation in a noncollagenous molecule. This suggests that a homologous NC1 domain at the C terminus
of a noncollagenous molecule, such as multimerin, may be responsible
for multimerization of this molecule. The multimeric state of
precerebellin, the other noncollagenous protein with a homologous NC1
domain at its C terminus, is not known. In the light of the present
data, it will be intriguing to test whether precerebellin forms trimers
and higher order multimers during synapse formation.
The structural features within the NC1(X) domain which direct trimer
and multimer formation remain to be determined. Computer analysis of
the secondary structure of the NC1(X) indicates that the NC1 peptide
may be a novel structural entity comprised of multiple We thank Phyllis LuValle for providing the
plasmid pYN3116, A. Daniel Jones for performing mass spectra, and Tom
Linsenmayer for critical reading of the manuscript.
*
This study was supported by National Institutes of Health
Grants AG14399 and AG000811 (to Q. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
An Arthritis Investigator from the Arthritis Foundation. To whom
correspondence should be addressed. Tel.: 717-531-4835; Fax: 717-531-7583; E-mail: qchen@ortho.hmc.psu.edu.
2
Y. Zhang and Q. Chen, unpublished data.
The abbreviations used are:
SMCD, Schmid
metaphyseal chondrodysplasia;
NC1, noncollagenous domain 1;
CMP, cartilage matrix protein;
PAGE, polyacrylamide gel electrophoresis;
PMSF, phenylmethylsulfonyl fluoride;
BS3, bis(sulfosuccinimidyl)suberate;
Ni-NTA, nickel nitrilotriacetic
acid.
The Noncollagenous Domain 1 of Type X Collagen
A NOVEL MOTIF FOR TRIMER AND HIGHER ORDER MULTIMER FORMATION
WITHOUT A TRIPLE HELIX*
§
Cell and Molecular
Physiology, The Pennsylvania State University College of Medicine,
Hershey, Pennsylvania 17033
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1(X) chains.
Each
1(X) chain contains three domains, a central helical domain
(COL1) flanked by the C-terminal and N-terminal noncollagenous domains
(NC1 and NC2) (12). The C-terminal NC1 domain appears to be essential
for at least some of the functions of type X collagen, because most of
the mutations identified in the SMCD patients have been localized there
(13, 14).
1(X). These data,
when taken together, suggest that the NC1 domain of type X from
different species plays a similar or identical roles, such as in the
assembly of type X collagen.
1(X) molecules that harbor
certain SMCD mutation are unable to form a triple helix as analyzed by
either in vitro translation (11) or cell transfections (16).
In addition, the NC1 domain of type X collagen may perform other
functions. Unlike the procollagen C-terminal extensions, which are
removed after a helix is assembled and secreted, the intact type X with
the NC1 domain is found in hypertrophic cartilage matrix (17). It may
mediate intermolecular associations of type X, such as formation
of a hexagonal lattice (6) and interactions with
proteoglycans (7).
1(X);
1 and
2 chains of type VIII collagen (18); a, b, and c
chains of C1q, the first component of the complement system (19); three
plasma proteins that are associated with mammalian hibernation, HP-20,
-25, and -27 (20); an adipose-specific protein that is dysregulated in obesity, AdipoQ (Acrp30) (21, 22); and an inner ear-specific protein
(23). The noncollagenous molecules include two chains of precerebellin,
which are expressed specifically in cerebellum during neurogenesis and
synapse formation (24); and multimerin, a massive protein found in
platelets and endothelial cells (25). Multimerin consists of a series
of varying sized disulfide-linked multimers, the smallest of which is a
homotrimer (26). The functions of NC1 in these noncollagenous molecules
are not known.

View larger version (24K):
[in a new window]
Fig. 1.
Schematic of known members of the NC1(X)
domain family. 1) Collagenous molecules:
1(X),
1(VIII),
2(VIII), C1qA, C1qB, C1qC, hibernation-associated proteins (HP):
HP-20, HP25, and HP-27, AdipoQ (Acrp30), and inner ear
specific protein. 2) Noncollagenous molecules: two forms of
precerebellin: one with a transmembrane domain, and one without a
transmembrane domain; and multimerin.
1(X). The peptide comprised only of the
NC1 domain, is sufficient to form a trimer and a series of higher order
multimers of this trimeric unit. The other peptide comprised of the NC1
domain plus a noncollagenous A domain from cartilage matrix protein
(matrilin 1) at the N terminus, forms homotrimers by itself, and a
series of heterotrimers with the NC1 peptide. These data suggest that
the NC1 domain of collagen X functions as a novel nucleation site for
trimer and multimer formation, both for collagenous and noncollagenous molecules.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1(X)
(Thr513 to Ile674) was amplified by polymerase
chain reaction from a plasmid pNY3116 (12, 27). The polymerase chain
reaction primers (5'-GCC CCG GGA CAA TCC CAG AAG GTT AT-3', and 5'-ATA
AGC TTA GAT TTG AGC AAA TAG-3') contained a XbaI and a
HindIII site at the respective 5' and 3' end. The fragment
was then cloned into a pQE32 (type IV) (Qiagen, Santa Clarita, CA) to
carry a six histidine-tag at its N terminus. For the A-NC1 construct, a
cDNA fragment (582 base pairs) of the A2 domain from avian
cartilage matrix protein (CMP) was amplified from a mini-CMP cDNA
(28) with a pair of primers carrying XbaI sites (5'-TTC CCG
GGG CTT GCA GTG GTG GGT CA-3', 5'-TTC CCG GGA TCT TCC TCA ACG CAG
AT-3'). After digestion with XbaI, the A2 fragment was
ligated into the XbaI site 5' upstream of the NC1 insert in
the expression vector. This ligation created a chimeric molecule with
the A2 domain at its 5' end and the NC1 domain at its 3' end.
Both cDNA constructs were sequenced to confirm the correct reading
frame and no spontaneous point mutations. The recombinant plasmids were
transfected into competent M15 Escherichia coli. The
expression of the His-tagged peptides were induced with 2 mM isopropylthio-
-D-galactoside.
-mercaptoethanol, 15% SDS, 1.5% bromphenol blue,
and 50% glycerol. For nonreducing conditions, the 4× loading buffer
contains 16% SDS and 1% bromphenol blue. Sometimes the nonreducing
buffer contains 2 M urea. The presence of urea in loading
buffer does not affect dissociation properties of NC1 peptides. Samples
were boiled for 10 min before loading when required. Gels were stained
with Coomassie Blue.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1(X), and thus comprises the entire NC1 domain (Fig.
2A). This peptide is devoid of
any triple helical (Gly-X-Y) residues, and thus
can be used to test whether the NC1 domain alone is sufficient to form
a trimer and higher order multimers.

View larger version (22K):
[in a new window]
Fig. 2.
Construction of the two molecules containing
the NC1 and experimental strategy. Question 1 (Q1): Is
the NC1 domain alone sufficient to form a trimer? Question 2 (Q2): Is the NC1 domain sufficient to form multimers?
Question 3 (Q3): Is the NC1 domain sufficient to direct
trimer formation of a noncollagenous molecule? Question 4 (Q4): Can the
NC1 peptide and the A-NC1 peptide form heterotrimers via the NC1
domain? A2, the second A domain in CMP; CC, the
coiled-coil domain at the C terminus of CMP.
-D-galactoside, E. coli
expressed a 20-kDa peptide (Fig.
3A). This is the molecular
mass predicted from the amino acid sequence of the peptide, and also of
the NC1 monomer from authentic type X collagen (30). The expressed
His-tagged NC1 peptide, when affinity purified from cytoplasm using
Ni-NTA resin under native conditions, produced a His-tag protein that
migrated on SDS-PAGE with a molecular mass of 45 kDa (Fig.
3B, lane 2). This apparent molecular weight is
the same as that of the NC1 trimer isolated by bacterial collagenase
digestion of authentic type X collagen from avian hypertrophic
chondrocytes (30). The NC1 trimer is 45 kDa instead of 60 kDa, because
of its compact conformation (30). Additional evidence for a trimeric
form will be presented later. Some of the 45-kDa band was shifted to
20-kDa monomer after heating at 100 °C in a SDS-containing buffer
(Fig. 3B, lane 3). This suggests that the native
NC1 peptide alone is sufficient to form a trimer.

View larger version (23K):
[in a new window]
Fig. 3.
Expression of the NC1(X) peptide in E. coil. A, expression of recombinant NC1(X)
was induced by 2 mM
isopropylthio-
-D-galactoside (lane 1);
negative control without induction (lane 2). The
arrow points to the induced 20-kDa peptide. Cell lysates
were heated for 10 min before loading. B, NC1(X) was
expressed and purified under native and denatured conditions. The NC1
peptides were purified with His-tag affinity chromatography, and
quantified by a BCA protein assay reagent kit (Pierce). SDS-PAGE
analysis was performed with an equal amount of purified peptides loaded
in each lane under reducing conditions. Lane 1, molecular
weight marker; lanes 2 and 3, the NC1 peptide
purified under native conditions; lane 4, the NC1 peptide
purified under denatured conditions (see "Methods and Material" for
details). As indicated, the peptides were either heated for 10 min at
100 °C or without heating prior to loading.

View larger version (44K):
[in a new window]
Fig. 4.
In vitro refolding of denatured NC1(X)
peptides. Purified NC1(X) peptide in a buffer containing 8 M urea was subjected to renaturation by a step wise
dilution of the denaturant. The refolding process was performed with
denatured NC1 peptides either in solution (lanes 2 and
3, liquid phase refolding), or immobilized on a column
(lanes 4 and 5, solid phase refolding).
Conditions such as the length of folding time and solutions used in
each step were identical between liquid and solid phase refolding. As
indicated, the samples were either heated for 10 min at 100 °C or
without heating prior to electrophoresis under reducing conditions.
Lane 1, molecular weight markers.

View larger version (12K):
[in a new window]
Fig. 5.
Thermostability of the NC1 (X) trimer.
The refolded NC1(X) peptides were subjected to heating at 70 °C
(lane 1), 80 °C (lane 2), 90 °C (lane
3), or 100 °C (lane 4) for 10 min before loading to
a 10% SDS-PAGE gel. As indicated, electrophoresis was performed under
both reducing and nonreducing conditions.

View larger version (57K):
[in a new window]
Fig. 6.
The NC1(X) peptide is sufficient to form
multimers. The NC1(X) peptide was cross-linked by BS3
for 1 h at room temperature. As indicated, the molar ratio of
BS3/NC1 was 0, 1, and 1,000, respectively. Samples were
loaded either after heating at 100 °C for 10 min or without heating
as indicated. The arrows point to a series of multimers
under both heating and nonheating conditions. The arrowheads
point to a large polymer formed under a condition with excessive
cross-linkers.

View larger version (66K):
[in a new window]
Fig. 7.
The A-NC1 peptide forms multimers.
Refolded A-NC1 peptides were subjected to electrophoresis under
reducing conditions on a 10% SDS-PAGE. Lanes 1,
2, and 3, the order of peptide collections eluted
from the refolding Ni-NTA column. The arrows indicate
monomers at 40 kDa, putative trimers at 100 kDa, and putative hexamers
at 200 kDa. Note more multimers were eluted in later collections, which
resulted from more interactions between His-tags and Ni-NTA in a
multimer than a monomer.

View larger version (77K):
[in a new window]
Fig. 8.
The A-NC1 and NC1 peptides form
heterotrimers. Co-refolded A-NC1 and NC1 peptides were subjected
to electrophoresis under reducing nonheating conditions.
Lanes A, B, and C, three
different collections of peptides eluted from the co-refolding Ni-NTA
column. The arrows point to the four co-refolding products.
1, (A-NC1)3; 2,
(A-NC1)2(NC1); 3, (A-NC1)(NC1)2; and 4, (NC1)3.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
sheets and
loops.2 The elucidation of
the three-dimensional structure of this domain will rely on x-ray
crystallography and mutational analysis of the peptide.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Schmid, T. M.,
and Linsenmayer, T. F.
(1983)
J. Biol. Chem.
258,
9504-9509 2.
Gibson, G. J.,
and Flint, M. H.
(1985)
J. Cell Biol.
101,
277-284 3.
Schmid, T. M.,
and Linsenmayer, T. F.
(1985)
Dev. Biol.
107,
373-381[CrossRef][Medline]
[Order article via Infotrieve]
4.
Gerstenfeld, L. C.,
and Landis, W. J.
(1991)
J. Cell Biol.
112,
501-513 5.
Schmid, T. M.,
and Linsenmayer, T. F.
(1990)
Dev. Biol.
138,
53-62[CrossRef][Medline]
[Order article via Infotrieve]
6.
Kwan, A. P.,
Cummings, C. E.,
Chapman, J. A.,
and Grant, M. E.
(1991)
J. Cell Biol.
114,
597-604 7.
Chen, Q.,
Linsenmayer, C.,
Gu, H.,
Schmid, T. M.,
and Linsenmayer, T. F.
(1992)
J. Cell Biol.
117,
687-694 8.
Chen, Q.,
Gibney, E.,
Fitch, J. M.,
Linsenmayer, C.,
Schmid, T. M.,
and Linsenmayer, T. F.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8046-8050 9.
Kwan, K. M.,
Pang, M. K.,
Zhou, S.,
Cowan, S. K.,
Kong, R. Y.,
Pfordte, T.,
Olsen, B. R.,
Sillence, D. O.,
Tam, P. P.,
and Cheah, K. S.
(1997)
J. Cell Biol.
136,
459-471 10.
Warman, M. L.,
Abbott, M.,
Apte, S. S.,
Hefferon, T.,
McIntosh, I.,
Cohn, D. H.,
Hecht, J. T.,
Olsen, B. R.,
and Francomano, C. A.
(1993)
Nat. Genet.
5,
79-82[CrossRef][Medline]
[Order article via Infotrieve]
11.
Chan, D.,
Cole, W. G.,
Rogers, J. G.,
and Bateman, J. F.
(1995)
J. Biol. Chem.
270 (9),
4558-4562 12.
Ninomiya, Y.,
Gordon, M.,
van der Rest, M.,
Schmid, T.,
Linsenmayer, T.,
and Olsen, B. R.
(1986)
J. Biol. Chem.
261,
5041-5050 13.
Chan, D.,
Weng, Y. M.,
Graham, H. K.,
Sillence, D. O.,
and Bateman, J. F.
(1998)
J. Clin. Invest.
101,
1490-1499[Medline]
[Order article via Infotrieve]
14.
McIntosh, I.,
Abbott, M. H.,
and Francomano, C. A.
(1995)
Hum. Mutat.
5,
121-125[CrossRef][Medline]
[Order article via Infotrieve]
15.
Reichenberger, E.,
Aigner, T.,
von der Mark, K.,
Stoss, H.,
and Bertling, W.
(1991)
Dev. Biol.
148,
562-572[CrossRef][Medline]
[Order article via Infotrieve]
16.
Chan, D.,
Weng, Y. M.,
Hocking, A. M.,
Golub, S.,
McQuillan, D. J.,
and Bateman, J. F.
(1996)
J. Biol. Chem.
271,
13566-13572 17.
Schmid, T. M.,
and Linsenmayer, T. F.
(1989)
Connect. Tissue Res.
20,
215-222[Medline]
[Order article via Infotrieve]
18.
Yamaguchi, N.,
Mayne, R.,
and Ninomiya, Y.
(1991)
J. Biol. Chem.
266,
4508-4513 19.
Reid, K. B.
(1983)
Biochem. Soc. Trans.
11,
1-12[Medline]
[Order article via Infotrieve]
20.
Takamatsu, N.,
Ohba, K.,
Kondo, J.,
Kondo, N.,
and Shiba, T.
(1993)
Mol. Cell. Biol.
13,
1516-1521 21.
Hu, E.,
Liang, P.,
and Spiegelman, B. M.
(1996)
J. Biol. Chem.
271,
10697-10703 22.
Scherer, P. E.,
Williams, S.,
Fogliano, M.,
Baldini, G.,
and Lodish, H. F.
(1995)
J. Biol. Chem.
270,
26746-26749 23.
Davis, J. G.,
Oberholtzer, J. C.,
Burns, F. R.,
and Greene, M. I.
(1995)
Science
267,
1031-1034 24.
Kavety, B.,
Jenkins, N. A.,
Fletcher, C. F.,
Copeland, N. G.,
and Morgan, J. I.
(1994)
Mol. Brain Res.
27,
152-156[Medline]
[Order article via Infotrieve]
25.
Hayward, C. P.
(1997)
Clin. Investig. Med.
20,
176-187[Medline]
[Order article via Infotrieve]
26.
Hayward, C. P.,
Hassell, J. A.,
Denomme, G. A.,
Rachubinski, R. A.,
Brown, C.,
and Kelton, J. G.
(1995)
J. Biol. Chem.
270,
18246-18251 27.
LuValle, P.,
Ninomiya, Y.,
Rosenblum, N. D.,
and Olsen, B. R.
(1988)
J. Biol. Chem.
263,
18378-18385 28.
Chen, Q.,
Johnson, D. M.,
Haudenschild, D. R.,
Tondravi, M. M.,
and Goetinck, P. F.
(1995)
Mol. Biol. Cell
6,
1743-1753[Abstract]
29.
Haudenschild, D. R.,
Tondravi, M. M.,
Hofer, U.,
Chen, Q.,
and Goetinck, P. F.
(1995)
J. Biol. Chem.
270,
23150-23154 30.
Schmid, T. M.,
and Linsenmayer, T. F.
(1984)
Biochemistry
23,
553-558[CrossRef][Medline]
[Order article via Infotrieve]
31.
Engel, J.,
and Prockop, D. J.
(1991)
Annu. Rev. Biophys. Biophys. Chem.
20,
137-152[CrossRef][Medline]
[Order article via Infotrieve]
32.
Mazzorana, M.,
Gruffat, H.,
Sergeant, A.,
and van der Rest, M.
(1993)
J. Biol. Chem.
268,
3029-3032 33.
Mechling, D. E.,
Gambee, J. E.,
Morris, N. P.,
Sakai, L. Y.,
Keene, D. R.,
Mayne, R.,
and Bachinger, H. P.
(1996)
J. Biol. Chem.
271,
13781-13785 34.
McLaughlin, S. H.,
and Bulleid, N. J.
(1998)
Biochem. J.
331,
793-800
35.
Schmid, T. M.,
Mayne, R.,
Bruns, R. R.,
and Linsenmayer, T. F.
(1984)
J. Ultrastruc. Res.
86,
186-191[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Khoshnoodi, J.-P. Cartailler, K. Alvares, A. Veis, and B. G. Hudson Molecular Recognition in the Assembly of Collagens: Terminal Noncollagenous Domains Are Key Recognition Modules in the Formation of Triple Helical Protomers J. Biol. Chem., December 15, 2006; 281(50): 38117 - 38121. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wilson, S. Freddi, D. Chan, K. S. E. Cheah, and J. F. Bateman Misfolding of Collagen X Chains Harboring Schmid Metaphyseal Chondrodysplasia Mutations Results in Aberrant Disulfide Bond Formation, Intracellular Retention, and Activation of the Unfolded Protein Response J. Biol. Chem., April 22, 2005; 280(16): 15544 - 15552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stephan, M. J. Sherratt, N. Hodson, C. A. Shuttleworth, and C. M. Kielty Expression and Supramolecular Assembly of Recombinant {alpha}1(VIII) and {alpha}2(VIII) Collagen Homotrimers J. Biol. Chem., May 14, 2004; 279(20): 21469 - 21477. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Waki, T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, et al. Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes: MOLECULAR STRUCTURE AND MULTIMER FORMATION OF ADIPONECTIN J. Biol. Chem., October 10, 2003; 278(41): 40352 - 40363. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kishore, S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. M. Reid Modular Organization of the Carboxyl-Terminal, Globular Head Region of Human C1q A, B, and C Chains J. Immunol., July 15, 2003; 171(2): 812 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kishore, P. Strong, M. V. Perdikoulis, and K. B. M. Reid A Recombinant Homotrimer, Composed of the {{alpha}} Helical Neck Region of Human Surfactant Protein D and C1q B Chain Globular Domain, Is an Inhibitor of the Classical Complement Pathway J. Immunol., January 1, 2001; 166(1): 559 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mongiat, G. Mungiguerra, S. Bot, M. T. Mucignat, E. Giacomello, R. Doliana, and A. Colombatti Self-assembly and Supramolecular Organization of EMILIN J. Biol. Chem., August 11, 2000; 275(33): 25471 - 25480. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and Q. Chen Changes of Matrilin Forms during Endochondral Ossification. MOLECULAR BASIS OF OLIGOMERIC ASSEMBLY J. Biol. Chem., October 13, 2000; 275(42): 32628 - 32634. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koide, A. Aso, T. Yorihuzi, and K. Nagata Conformational Requirements of Collagenous Peptides for Recognition by the Chaperone Protein HSP47 J. Biol. Chem., September 1, 2000; 275(36): 27957 - 27963. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boutaud, D.-B. Borza, O. Bondar, S. Gunwar, K.-O. Netzer, N. Singh, Y. Ninomiya, Y. Sado, M. E. Noelken, and B. G. Hudson Type IV Collagen of the Glomerular Basement Membrane. EVIDENCE THAT THE CHAIN SPECIFICITY OF NETWORK ASSEMBLY IS ENCODED BY THE NONCOLLAGENOUS NC1 DOMAINS J. Biol. Chem., September 22, 2000; 275(39): 30716 - 30724. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||